<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33503">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01963819</url>
  </required_header>
  <id_info>
    <org_study_id>Miacol-2013-1H</org_study_id>
    <nct_id>NCT01963819</nct_id>
  </id_info>
  <brief_title>Therapeutic Endometrial Biopsy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <authority>Denmark: Danish Dataprotection Agency</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the potential benefits in implantation, clinical
      pregnancy and live birth rates by an endometrial biopsy prior to an IVF/ICSI treatment.
      Including a follow up on possible pregnancy complications and data on children at birth.

      Further it is planned to aspirate secretions from the uterus and take blood samples during
      the treatment, which presumably can provide information about the mechanisms underlying the
      possible effect of the treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized controlled prospective clinical study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">October 2016</completion_date>
  <primary_completion_date type="Anticipated">October 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Rate of clinical pregnancy</measure>
    <time_frame>Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of biochemical pregnancy</measure>
    <time_frame>Individual outcome will be evaluated within 8 weeks after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of implantation</measure>
    <time_frame>Individual outcome will be evaluated within 8 weekes after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of live birth</measure>
    <time_frame>Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of pregnancy complications</measure>
    <time_frame>Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Placenta abnormalities, pregnancy related hypetensive disorders, IUGR, GDM</description>
  </other_outcome>
  <other_outcome>
    <measure>Data on children and placenta at birth</measure>
    <time_frame>Individual outcome will be evaluated within 9 months after embryo transfer. Overall outcome will be evaluated after 3 years.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Gestationel age, Preterm birth, LGA/SGA/NGA, Gender, Placenta abnormalities</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Infertility</condition>
  <condition>Endometrium</condition>
  <condition>ART</condition>
  <condition>Endometrial Biopsy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endometrial biopsy before standard treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endometrial biopsy</intervention_name>
    <description>The endometrial biopsy will be done in the luteal phase (cycle day 18-22) prior to the treatment cycle (antagonist)</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Endometrial scratching</other_name>
    <other_name>Endometrial injury</other_name>
    <other_name>Local injury to the endometrium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One or more previous failed implantation despite transfer of good            quality
             embryons/blastocyst in a fresh IVF/ICSI treatment

          -  Planned Antagonist treatment

          -  Planned Standardized hormone treatment

          -  FSH: 2-12 IU/L

          -  Age: 18-40 years

          -  BMI: 18-32

          -  Regular menstrual cycles

          -  Written consent

        Exclusion Criteria:

          -  Patients in need for a interpreter

          -  Suspected intrauterine abnormalities ( fibromes, polyps, adenomyosis, sactosalpinges)

          -  Planned use og Assisted hatching or use of specialized media

          -  Previous inclusion in the study
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Forman, MD, DMsc</last_name>
    <role>Study Director</role>
    <affiliation>Departement of Gynaecology and Obstetrics, Aarhus University Hospital, Skejby</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Inge E Agerholm, M.Sc, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic, Horsens Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Benedicte Hauge, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic, Horsens Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Humaidan, MD, DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic, Skive Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mia Steengaard Olesen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fertility Clinic Horsens Hospital, Aarhus University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mia Steengaard Olesen, MD</last_name>
    <phone>+4578426562</phone>
    <email>miaolsen@rm.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Axel Forman, MD, DMsc</last_name>
    <email>axel.forman@ki.au.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fertility Clinic, Dronninglund Hospital (Aalborg University Hospital)</name>
      <address>
        <city>Dronninglund</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fertility Clinic, Horsens Hospital</name>
      <address>
        <city>Horsens</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mia Steengaard Olesen, MD</last_name>
      <email>miaolsen@rm.dk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fertility Clinic, Skive Hospital</name>
      <address>
        <city>Skive</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>February 27, 2014</lastchanged_date>
  <firstreceived_date>October 11, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
